Global Stress Medication Market Research Report 2023

Stress medications are an easy way to combat anxiety and stress. Anxiety drugs are designed specifically to provide near-instant relief from your anxiety symptoms, and although some can still take a few weeks to work, they represent a faster method than therapy and some of the at-home stress reduction techniques.

The global Stress Medication market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Stress Medication is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Stress Medication is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Stress Medication in Children is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Stress Medication include Actavis Generics, Sanofi, Dainippon Sumitomo, Janssen Pharmaceuticals, Pfizer, Intra-Cellular Therapies, Inc., Alkermes, Otsuka Pharmaceutical and Allergan, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Stress Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stress Medication.

The Stress Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Stress Medication market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stress Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stress Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Antidepressant Drugs

1.2.3 Atypical Antipsychotics

1.2.4 Benzodiazepines Medicals

1.3 Market by Application

1.3.1 Global Stress Medication Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Children

1.3.3 Adults

1.3.4 Elderly

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Stress Medication Market Perspective (2018-2029)

2.2 Stress Medication Growth Trends by Region

2.2.1 Global Stress Medication Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Stress Medication Historic Market Size by Region (2018-2023)

2.2.3 Stress Medication Forecasted Market Size by Region (2024-2029)

2.3 Stress Medication Market Dynamics

2.3.1 Stress Medication Industry Trends

2.3.2 Stress Medication Market Drivers

2.3.3 Stress Medication Market Challenges

2.3.4 Stress Medication Market Restraints

3.1 Global Top Stress Medication Players by Revenue

3.1.1 Global Top Stress Medication Players by Revenue (2018-2023)

3.1.2 Global Stress Medication Revenue Market Share by Players (2018-2023)

3.2 Global Stress Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Stress Medication Revenue

3.4 Global Stress Medication Market Concentration Ratio

3.4.1 Global Stress Medication Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stress Medication Revenue in 2022

3.5 Stress Medication Key Players Head office and Area Served

3.6 Key Players Stress Medication Product Solution and Service

3.7 Date of Enter into Stress Medication Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Stress Medication Historic Market Size by Type (2018-2023)

4.2 Global Stress Medication Forecasted Market Size by Type (2024-2029)

5.1 Global Stress Medication Historic Market Size by Application (2018-2023)

5.2 Global Stress Medication Forecasted Market Size by Application (2024-2029)

6.1 North America Stress Medication Market Size (2018-2029)

6.2 North America Stress Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Stress Medication Market Size by Country (2018-2023)

6.4 North America Stress Medication Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Stress Medication Market Size (2018-2029)

7.2 Europe Stress Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Stress Medication Market Size by Country (2018-2023)

7.4 Europe Stress Medication Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Stress Medication Market Size (2018-2029)

8.2 Asia-Pacific Stress Medication Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Stress Medication Market Size by Region (2018-2023)

8.4 Asia-Pacific Stress Medication Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Stress Medication Market Size (2018-2029)

9.2 Latin America Stress Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Stress Medication Market Size by Country (2018-2023)

9.4 Latin America Stress Medication Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Stress Medication Market Size (2018-2029)

10.2 Middle East & Africa Stress Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Stress Medication Market Size by Country (2018-2023)

10.4 Middle East & Africa Stress Medication Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Actavis Generics

11.1.1 Actavis Generics Company Detail

11.1.2 Actavis Generics Business Overview

11.1.3 Actavis Generics Stress Medication Introduction

11.1.4 Actavis Generics Revenue in Stress Medication Business (2018-2023)

11.1.5 Actavis Generics Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Detail

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Stress Medication Introduction

11.2.4 Sanofi Revenue in Stress Medication Business (2018-2023)

11.2.5 Sanofi Recent Development

11.3 Dainippon Sumitomo

11.3.1 Dainippon Sumitomo Company Detail

11.3.2 Dainippon Sumitomo Business Overview

11.3.3 Dainippon Sumitomo Stress Medication Introduction

11.3.4 Dainippon Sumitomo Revenue in Stress Medication Business (2018-2023)

11.3.5 Dainippon Sumitomo Recent Development

11.4 Janssen Pharmaceuticals

11.4.1 Janssen Pharmaceuticals Company Detail

11.4.2 Janssen Pharmaceuticals Business Overview

11.4.3 Janssen Pharmaceuticals Stress Medication Introduction

11.4.4 Janssen Pharmaceuticals Revenue in Stress Medication Business (2018-2023)

11.4.5 Janssen Pharmaceuticals Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Detail

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Stress Medication Introduction

11.5.4 Pfizer Revenue in Stress Medication Business (2018-2023)

11.5.5 Pfizer Recent Development

11.6 Intra-Cellular Therapies, Inc.

11.6.1 Intra-Cellular Therapies, Inc. Company Detail

11.6.2 Intra-Cellular Therapies, Inc. Business Overview

11.6.3 Intra-Cellular Therapies, Inc. Stress Medication Introduction

11.6.4 Intra-Cellular Therapies, Inc. Revenue in Stress Medication Business (2018-2023)

11.6.5 Intra-Cellular Therapies, Inc. Recent Development

11.7 Alkermes

11.7.1 Alkermes Company Detail

11.7.2 Alkermes Business Overview

11.7.3 Alkermes Stress Medication Introduction

11.7.4 Alkermes Revenue in Stress Medication Business (2018-2023)

11.7.5 Alkermes Recent Development

11.8 Otsuka Pharmaceutical

11.8.1 Otsuka Pharmaceutical Company Detail

11.8.2 Otsuka Pharmaceutical Business Overview

11.8.3 Otsuka Pharmaceutical Stress Medication Introduction

11.8.4 Otsuka Pharmaceutical Revenue in Stress Medication Business (2018-2023)

11.8.5 Otsuka Pharmaceutical Recent Development

11.9 Allergan

11.9.1 Allergan Company Detail

11.9.2 Allergan Business Overview

11.9.3 Allergan Stress Medication Introduction

11.9.4 Allergan Revenue in Stress Medication Business (2018-2023)

11.9.5 Allergan Recent Development

11.10 Hikma Pharmaceuticals

11.10.1 Hikma Pharmaceuticals Company Detail

11.10.2 Hikma Pharmaceuticals Business Overview

11.10.3 Hikma Pharmaceuticals Stress Medication Introduction

11.10.4 Hikma Pharmaceuticals Revenue in Stress Medication Business (2018-2023)

11.10.5 Hikma Pharmaceuticals Recent Development

11.11 Actiza Pharma

11.11.1 Actiza Pharma Company Detail

11.11.2 Actiza Pharma Business Overview

11.11.3 Actiza Pharma Stress Medication Introduction

11.11.4 Actiza Pharma Revenue in Stress Medication Business (2018-2023)

11.11.5 Actiza Pharma Recent Development

11.12 Eli Lilly

11.12.1 Eli Lilly Company Detail

11.12.2 Eli Lilly Business Overview

11.12.3 Eli Lilly Stress Medication Introduction

11.12.4 Eli Lilly Revenue in Stress Medication Business (2018-2023)

11.12.5 Eli Lilly Recent Development

11.13 AstraZeneca

11.13.1 AstraZeneca Company Detail

11.13.2 AstraZeneca Business Overview

11.13.3 AstraZeneca Stress Medication Introduction

11.13.4 AstraZeneca Revenue in Stress Medication Business (2018-2023)

11.13.5 AstraZeneca Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Stress Medication Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Antidepressant Drugs

    Table 3. Key Players of Atypical Antipsychotics

    Table 4. Key Players of Benzodiazepines Medicals

    Table 5. Global Stress Medication Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Stress Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Stress Medication Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Stress Medication Market Share by Region (2018-2023)

    Table 9. Global Stress Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Stress Medication Market Share by Region (2024-2029)

    Table 11. Stress Medication Market Trends

    Table 12. Stress Medication Market Drivers

    Table 13. Stress Medication Market Challenges

    Table 14. Stress Medication Market Restraints

    Table 15. Global Stress Medication Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Stress Medication Market Share by Players (2018-2023)

    Table 17. Global Top Stress Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stress Medication as of 2022)

    Table 18. Ranking of Global Top Stress Medication Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Stress Medication Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Stress Medication Product Solution and Service

    Table 22. Date of Enter into Stress Medication Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Stress Medication Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Stress Medication Revenue Market Share by Type (2018-2023)

    Table 26. Global Stress Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Stress Medication Revenue Market Share by Type (2024-2029)

    Table 28. Global Stress Medication Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Stress Medication Revenue Market Share by Application (2018-2023)

    Table 30. Global Stress Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Stress Medication Revenue Market Share by Application (2024-2029)

    Table 32. North America Stress Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Stress Medication Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Stress Medication Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Stress Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Stress Medication Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Stress Medication Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Stress Medication Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Stress Medication Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Stress Medication Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Stress Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Stress Medication Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Stress Medication Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Stress Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Stress Medication Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Stress Medication Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Actavis Generics Company Detail

    Table 48. Actavis Generics Business Overview

    Table 49. Actavis Generics Stress Medication Product

    Table 50. Actavis Generics Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 51. Actavis Generics Recent Development

    Table 52. Sanofi Company Detail

    Table 53. Sanofi Business Overview

    Table 54. Sanofi Stress Medication Product

    Table 55. Sanofi Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 56. Sanofi Recent Development

    Table 57. Dainippon Sumitomo Company Detail

    Table 58. Dainippon Sumitomo Business Overview

    Table 59. Dainippon Sumitomo Stress Medication Product

    Table 60. Dainippon Sumitomo Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 61. Dainippon Sumitomo Recent Development

    Table 62. Janssen Pharmaceuticals Company Detail

    Table 63. Janssen Pharmaceuticals Business Overview

    Table 64. Janssen Pharmaceuticals Stress Medication Product

    Table 65. Janssen Pharmaceuticals Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 66. Janssen Pharmaceuticals Recent Development

    Table 67. Pfizer Company Detail

    Table 68. Pfizer Business Overview

    Table 69. Pfizer Stress Medication Product

    Table 70. Pfizer Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 71. Pfizer Recent Development

    Table 72. Intra-Cellular Therapies, Inc. Company Detail

    Table 73. Intra-Cellular Therapies, Inc. Business Overview

    Table 74. Intra-Cellular Therapies, Inc. Stress Medication Product

    Table 75. Intra-Cellular Therapies, Inc. Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 76. Intra-Cellular Therapies, Inc. Recent Development

    Table 77. Alkermes Company Detail

    Table 78. Alkermes Business Overview

    Table 79. Alkermes Stress Medication Product

    Table 80. Alkermes Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 81. Alkermes Recent Development

    Table 82. Otsuka Pharmaceutical Company Detail

    Table 83. Otsuka Pharmaceutical Business Overview

    Table 84. Otsuka Pharmaceutical Stress Medication Product

    Table 85. Otsuka Pharmaceutical Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 86. Otsuka Pharmaceutical Recent Development

    Table 87. Allergan Company Detail

    Table 88. Allergan Business Overview

    Table 89. Allergan Stress Medication Product

    Table 90. Allergan Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 91. Allergan Recent Development

    Table 92. Hikma Pharmaceuticals Company Detail

    Table 93. Hikma Pharmaceuticals Business Overview

    Table 94. Hikma Pharmaceuticals Stress Medication Product

    Table 95. Hikma Pharmaceuticals Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 96. Hikma Pharmaceuticals Recent Development

    Table 97. Actiza Pharma Company Detail

    Table 98. Actiza Pharma Business Overview

    Table 99. Actiza Pharma Stress Medication Product

    Table 100. Actiza Pharma Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 101. Actiza Pharma Recent Development

    Table 102. Eli Lilly Company Detail

    Table 103. Eli Lilly Business Overview

    Table 104. Eli Lilly Stress Medication Product

    Table 105. Eli Lilly Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 106. Eli Lilly Recent Development

    Table 107. AstraZeneca Company Detail

    Table 108. AstraZeneca Business Overview

    Table 109. AstraZeneca Stress Medication Product

    Table 110. AstraZeneca Revenue in Stress Medication Business (2018-2023) & (US$ Million)

    Table 111. AstraZeneca Recent Development

    Table 112. Research Programs/Design for This Report

    Table 113. Key Data Information from Secondary Sources

    Table 114. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Stress Medication Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Stress Medication Market Share by Type: 2022 VS 2029

    Figure 3. Antidepressant Drugs Features

    Figure 4. Atypical Antipsychotics Features

    Figure 5. Benzodiazepines Medicals Features

    Figure 6. Global Stress Medication Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Stress Medication Market Share by Application: 2022 VS 2029

    Figure 8. Children Case Studies

    Figure 9. Adults Case Studies

    Figure 10. Elderly Case Studies

    Figure 11. Stress Medication Report Years Considered

    Figure 12. Global Stress Medication Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Stress Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Stress Medication Market Share by Region: 2022 VS 2029

    Figure 15. Global Stress Medication Market Share by Players in 2022

    Figure 16. Global Top Stress Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stress Medication as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Stress Medication Revenue in 2022

    Figure 18. North America Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Stress Medication Market Share by Country (2018-2029)

    Figure 20. United States Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Stress Medication Market Share by Country (2018-2029)

    Figure 24. Germany Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Stress Medication Market Share by Region (2018-2029)

    Figure 32. China Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Stress Medication Market Share by Country (2018-2029)

    Figure 40. Mexico Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Stress Medication Market Share by Country (2018-2029)

    Figure 44. Turkey Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Stress Medication Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Actavis Generics Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 47. Sanofi Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 48. Dainippon Sumitomo Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 49. Janssen Pharmaceuticals Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 50. Pfizer Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 51. Intra-Cellular Therapies, Inc. Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 52. Alkermes Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 53. Otsuka Pharmaceutical Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 54. Allergan Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 55. Hikma Pharmaceuticals Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 56. Actiza Pharma Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 57. Eli Lilly Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 58. AstraZeneca Revenue Growth Rate in Stress Medication Business (2018-2023)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed